Publications by authors named "Crystal L Mackall"

100Publications

The Emerging Landscape of Immune Cell Therapies.

Cell 2020 04;181(1):46-62

Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2020.03.001DOI Listing
April 2020

Clinical lessons learned from the first leg of the CAR T cell journey.

Nat Med 2019 09 9;25(9):1341-1355. Epub 2019 Sep 9.

Department of Pediatrics, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41591-019-0564-6
Publisher Site
http://dx.doi.org/10.1038/s41591-019-0564-6DOI Listing
September 2019

Programming CAR-T cells to kill cancer.

Nat Biomed Eng 2018 06 11;2(6):377-391. Epub 2018 Jun 11.

Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41551-018-0235-9
Publisher Site
http://dx.doi.org/10.1038/s41551-018-0235-9DOI Listing
June 2018

CAR T cell therapy: inroads to response and resistance.

Nat Rev Immunol 2019 02;19(2):73-74

Ernest and Amelia Gallo Family Professor of Pediatrics and Medicine, Stanford University, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41577-018-0119-yDOI Listing
February 2019

Tumor Antigen Escape from CAR T-cell Therapy.

Cancer Discov 2018 10 22;8(10):1219-1226. Epub 2018 Aug 22.

Department of Pediatrics, Stanford University School of Medicine, Stanford, California.

View Article

Download full-text PDF

Source
http://cancerdiscovery.aacrjournals.org/lookup/doi/10.1158/2
Publisher Site
http://dx.doi.org/10.1158/2159-8290.CD-18-0442DOI Listing
October 2018

Fludarabine and neurotoxicity in engineered T-cell therapy.

Gene Ther 2018 06 7;25(3):176-191. Epub 2018 May 7.

Adaptimmune, Oxford, UK, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41434-018-0019-6DOI Listing
June 2018

Neurotoxicity Associated with a High-Affinity GD2 CAR-Letter.

Cancer Immunol Res 2018 04;6(4):494-495

Department of Pediatrics, Stanford University School of Medicine, Palo Alto, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-18-0089DOI Listing
April 2018

Engineering a designer immunotherapy.

Science 2018 03;359(6379):990-991

Department of Pediatrics and Medicine, and Stanford Cancer Institute, 265 Campus Way, G3141A, Stanford University, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/science.aas9434DOI Listing
March 2018

Immunotherapy for acute lymphoblastic leukemia: from famine to feast.

Blood Adv 2016 Dec 27;1(3):265-269. Epub 2016 Dec 27.

Department of Pediatrics and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2016000034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737176PMC
December 2016

CNS Endothelial Cell Activation Emerges as a Driver of CAR T Cell-Associated Neurotoxicity.

Cancer Discov 2017 12;7(12):1371-1373

Stanford Cancer Institute, Stanford University, Stanford, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-17-1084DOI Listing
December 2017

Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma.

Cancer Cell 2017 09;32(3):295-309.e12

Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Colket Translational Research Building, 3501 Civic Center Boulevard, Philadelphia, PA 19104, USA; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2017.08.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600520PMC
September 2017

Harnessing the Immunotherapy Revolution for the Treatment of Childhood Cancers.

Cancer Cell 2017 04 30;31(4):476-485. Epub 2017 Mar 30.

Department of Pediatrics, Stanford University, Stanford, CA 94305, USA; Parker Institute for Cancer Immunotherapy at Stanford, Stanford Cancer Institute, Stanford University, 265 Campus Drive, G3141A, MC5456, Stanford, CA 94305, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15356108173006
Publisher Site
http://dx.doi.org/10.1016/j.ccell.2017.03.002DOI Listing
April 2017

Autologous lymphapheresis for the production of chimeric antigen receptor T cells.

Transfusion 2017 05 24;57(5):1133-1141. Epub 2017 Feb 24.

Department of Transfusion Medicine, NIH Clinical Center, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.14003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398918PMC
May 2017

Neuroblastoma.

Nat Rev Dis Primers 2016 11 10;2:16078. Epub 2016 Nov 10.

Department of Pediatrics and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California 94158, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrdp.2016.78DOI Listing
November 2016

Induction of Immune Response after Allogeneic Wilms' Tumor 1 Dendritic Cell Vaccination and Donor Lymphocyte Infusion in Patients with Hematologic Malignancies and Post-Transplantation Relapse.

Biol Blood Marrow Transplant 2016 12 12;22(12):2149-2154. Epub 2016 Sep 12.

Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.08.028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499897PMC
December 2016

Reduction of MDSCs with All-trans Retinoic Acid Improves CAR Therapy Efficacy for Sarcomas.

Cancer Immunol Res 2016 10 22;4(10):869-880. Epub 2016 Aug 22.

Pediatric Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland. Department of Pediatrics, Stanford University School of Medicine, Stanford, California.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5050151PMC
http://dx.doi.org/10.1158/2326-6066.CIR-15-0230DOI Listing
October 2016

Myeloid cells in peripheral blood mononuclear cell concentrates inhibit the expansion of chimeric antigen receptor T cells.

Cytotherapy 2016 07 17;18(7):893-901. Epub 2016 May 17.

Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcyt.2016.04.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898642PMC
July 2016

Adjuvant Immunotherapy to Improve Outcome in High-Risk Pediatric Sarcomas.

Clin Cancer Res 2016 07 28;22(13):3182-91. Epub 2016 Jan 28.

Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH Clinical Center, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-2550DOI Listing
July 2016

Emerging Immunotherapies for Cancer and Their Potential for Application in Pediatric Oncology.

Crit Rev Oncog 2015 ;20(3-4):315-27

Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1615/critrevoncog.2015013861DOI Listing
June 2016

Going back to class I: MHC and immunotherapies for childhood cancer.

Pediatr Blood Cancer 2015 Apr 18;62(4):571-6. Epub 2014 Dec 18.

Division of Hematology/Oncology/Blood and Marrow Transplant, Nationwide Children's Hospital, Columbus, Ohio.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pbc.25359
Publisher Site
http://dx.doi.org/10.1002/pbc.25359DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339346PMC
April 2015

Immune-based therapies for childhood cancer.

Nat Rev Clin Oncol 2014 Dec 28;11(12):693-703. Epub 2014 Oct 28.

Paediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, 10 Center Drive, MSC 1104, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2014.177DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953414PMC
December 2014

Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy.

Sci Transl Med 2014 May;6(237):237ra67

Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.3007974DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6980372PMC
May 2014

Mass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens.

Biomark Med 2014 ;8(2):269-86

Laboratory of Proteomics & Analytical Technologies, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, National Cancer Institute at Frederick, PO Box B, Frederick, MD 21702, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/bmm.13.101DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201940PMC
October 2014

T-cell adoptive immunotherapy for acute lymphoblastic leukemia.

Hematology Am Soc Hematol Educ Program 2013 ;2013:348-53

1Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2013.1.348DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569491PMC
December 2014

A pan-inhibitor of DASH family enzymes induces immune-mediated regression of murine sarcoma and is a potent adjuvant to dendritic cell vaccination and adoptive T-cell therapy.

J Immunother 2013 Oct;36(8):400-11

*Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD †Department of Pediatrics, Division of Pediatric Hematology/Oncology, MedStar Georgetown University Hospital, Washington, DC ‡Department of Biochemistry, Tufts University School of Medicine, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0b013e3182a80213DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852174PMC
October 2013

Highlights of the third International Conference on Immunotherapy in Pediatric Oncology.

Pediatr Hematol Oncol 2013 Aug 12;30(5):349-66. Epub 2013 Jun 12.

Department for Stem Cell Transplantation and Immunology, J.W. Goethe-University Hospital, University Hospital for Children and Adolescents, Frankfurt/Main, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/08880018.2013.802106DOI Listing
August 2013

Fibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer.

Blood 2013 Aug 11;122(7):1105-13. Epub 2013 Jun 11.

Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2012-08-449413DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744987PMC
August 2013

Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunity.

Proc Natl Acad Sci U S A 2013 May 22;110(19):E1761-70. Epub 2013 Apr 22.

Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1222303110DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651437PMC
May 2013

Identification of cell surface proteins as potential immunotherapy targets in 12 pediatric cancers.

Front Oncol 2012 17;2:194. Epub 2012 Dec 17.

Immunology Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2012.00194DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3523547PMC
December 2012

Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia.

Blood 2013 Feb 14;121(7):1165-74. Epub 2012 Dec 14.

Pediatric Oncology Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2012-06-438002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575759PMC
February 2013

Phase I trial and pharmacokinetic study of lexatumumab in pediatric patients with solid tumors.

J Clin Oncol 2012 Nov 15;30(33):4141-7. Epub 2012 Oct 15.

National Cancer Institute, National Institutes of Health, 10 Center Dr, Building 10 CRC, Room 1W-3750, Bethesda, MD 20892-1104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.44.1055DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494837PMC
November 2012

IL-7 in human health and disease.

Semin Immunol 2012 Jun 10;24(3):218-24. Epub 2012 Mar 10.

Pediatric Oncology Branch, National Cancer Institute, 10 Center Drive, Bethesda, MD 20892, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.smim.2012.02.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358500PMC
June 2012

Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomas.

Biol Blood Marrow Transplant 2012 May 5;18(5):698-707. Epub 2011 Sep 5.

Pediatric Oncology Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S108387911100367
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2011.08.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262116PMC
May 2012

Highlights of the second international conference on "Immunotherapy in Pediatric Oncology".

Pediatr Hematol Oncol 2011 Sep;28(6):459-60

Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/08880018.2011.596615DOI Listing
September 2011

Harnessing the biology of IL-7 for therapeutic application.

Nat Rev Immunol 2011 May;11(5):330-42

Immunology Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nri2970DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351348PMC
May 2011

Murine rhabdomyosarcoma is immunogenic and responsive to T-cell-based immunotherapy.

Pediatr Blood Cancer 2011 Dec 1;57(6):921-9. Epub 2011 Apr 1.

Immunology Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.23048DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401311PMC
December 2011

In search of targeted therapies for childhood cancer.

Front Oncol 2011 20;1:18. Epub 2011 Jul 20.

Pediatric Oncology Branch, National Cancer Institute Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2011.00018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356018PMC
August 2012

Novel gamma-chain cytokines as candidate immune modulators in immune therapies for cancer.

Cancer J 2010 Jul-Aug;16(4):392-8

Dunn School of Pathology, University of Oxford and The Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0b013e3181eacbc4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959548PMC
December 2010

T-cell-based therapies for malignancy and infection in childhood.

Pediatr Clin North Am 2010 Feb;57(1):83-96

Department of Pediatrics, Center for Cell and Gene Therapy, Baylor College of Medicine, 1102 Bates Street, Suite 1770, MC3-3320, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pcl.2009.11.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844874PMC
February 2010

Cytokines as Adjuvants for Vaccine and Cellular Therapies for Cancer.

Am J Immunol 2009 Jan;5(3):65-83

Immunology Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2826803PMC
http://dx.doi.org/10.3844/ajisp.2009.65.83DOI Listing
January 2009

Perspective on potential clinical applications of recombinant human interleukin-7.

Ann N Y Acad Sci 2009 Dec;1182:28-38

Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, DHHS, Bethesda, Maryland 20892-1104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1749-6632.2009.05075.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545488PMC
December 2009

Immunotherapy of childhood cancer: from biologic understanding to clinical application.

Curr Opin Pediatr 2010 Feb;22(1):2-11

Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Room #1-3750, 9000 Rockville Pike, MSC 1104, Bethesda, MD 20892-1104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOP.0b013e3283350d3eDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845444PMC
February 2010

Immune-based therapeutics for pediatric cancer.

Expert Opin Biol Ther 2010 Feb;10(2):163-78

National Cancer Institute, National Institutes of Health, Center for Cancer Research, Pediatric Oncology Branch, 10 Center Drive, MSC 1104, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712590903431022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809805PMC
February 2010

Current approach to pediatric soft tissue sarcomas.

Oncologist 2009 Nov 6;14(11):1139-53. Epub 2009 Nov 6.

Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2009-0160DOI Listing
November 2009

Clinical implications of immune reconstitution following hematopoietic stem cell transplantation.

Cancer Treat Res 2009 ;144:131-54

Royal Free and University College London Medical Schools, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-0-387-78580-6_6DOI Listing
September 2010

Harnessing the physiology of lymphopenia to support adoptive immunotherapy in lymphoreplete hosts.

Blood 2009 Oct 24;114(18):3831-40. Epub 2009 Aug 24.

Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2009-03-212134DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2773493PMC
October 2009

Highlights of the First International "Immunotherapy in Pediatric Oncology: Progress and Challenges" Meeting.

J Pediatr Hematol Oncol 2009 Apr;31(4):227-44

Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0b013e31819a5d8dDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714285PMC
April 2009

Bone marrow deficient in IFN-{gamma} signaling selectively reverses GVHD-associated immunosuppression and enhances a tumor-specific GVT effect.

Blood 2009 May 3;113(20):5002-9. Epub 2009 Mar 3.

Immunology Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2008-11-187385DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686147PMC
May 2009

Unusual sites of extraskeletal metastases of Ewing sarcoma after allogeneic hematopoietic stem cell transplantation.

J Pediatr Hematol Oncol 2009 Feb;31(2):142-4

Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0b013e31819146e5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2644462PMC
February 2009

GVHD: a continuing barrier to the safety of allogeneic transplantation.

Biol Blood Marrow Transplant 2009 Jan;15(1 Suppl):162-8

Department of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2008.10.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2633357PMC
January 2009

Antigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approaches.

Cancer Immunol Immunother 2009 Aug 13;58(8):1257-64. Epub 2009 Jan 13.

Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute/National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-008-0638-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791794PMC
August 2009

Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cells.

Nat Immunol 2009 Feb 11;10(2):149-57. Epub 2009 Jan 11.

Pediatric Oncology Branch, National Cancer Institute, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ni.1695DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713006PMC
February 2009

Generation, affinity maturation, and characterization of a human anti-human NKG2D monoclonal antibody with dual antagonistic and agonistic activity.

J Mol Biol 2008 Dec 16;384(5):1143-56. Epub 2008 Sep 16.

Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmb.2008.09.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2659651PMC
December 2008

Metabolic syndrome traits in long-term survivors of pediatric sarcoma.

Pediatr Blood Cancer 2008 Feb;50(2):341-6

Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.21363DOI Listing
February 2008